Cargando…

The LINC01260 Functions as a Tumor Suppressor via the miR-562/CYLD/NF-κB Pathway in Non-Small Cell Lung Cancer

PURPOSE: Recently, long noncoding RNAs (lncRNAs) have been identified as novel and potential therapeutic targets in various cancer types. Nonetheless, the levels and biological effects of lncRNAs in non-small cell lung cancer (NSCLC) remain largely unknown. In this study, we aimed to identify the ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yangming, Lei, Yujie, Lin, Jianbin, Huang, Yunchao, Zhang, Jiguang, Chen, Kai, Sun, Shihui, Lin, Xing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585791/ https://www.ncbi.nlm.nih.gov/pubmed/33116647 http://dx.doi.org/10.2147/OTT.S253730

Ejemplares similares

The role and possible mechanism of the long noncoding RNA LINC01260 in nonalcoholic fatty liver disease
por: Ge, Xiaoxiao, et al.
Publicado: (2022)

Expression of CYLD and NF-κB in Human Cholesteatoma Epithelium
por: Byun, Jae Yong, et al.
Publicado: (2010)

Mxi1 participates in the progression of lung cancer via the microRNA-300/KLF9/GADD34 Axis
por: Lei, Yujie, et al.
Publicado: (2022)

Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer
por: Masoumi, K. C., et al.
Publicado: (2011)

Optineurin Is Required for CYLD-Dependent Inhibition of TNFα-Induced NF-κB Activation
por: Nagabhushana, Ananthamurthy, et al.
Publicado: (2011)

Potential role for the tumor suppressor CYLD in brain and notochord development
por: Li, Te, et al.
Publicado: (2021)

Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency
por: Bekas, Nikolaos, et al.
Publicado: (2023)

Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD
por: Hövelmeyer, Nadine, et al.
Publicado: (2007)

The tumour suppressor CYLD regulates the p53 DNA damage response
por: Fernández-Majada, Vanesa, et al.
Publicado: (2016)

The Tumor Suppressor CYLD Interacts with TRIP and Regulates Negatively Nuclear Factor κB Activation by Tumor Necrosis Factor
por: Regamey, Alexandre, et al.
Publicado: (2003)

Downregulation of miR-181b inhibits human colon cancer cell proliferation by targeting CYLD and inhibiting the NF-κB signaling pathway
por: Yang, Xifeng, et al.
Publicado: (2020)

CYLD Deubiquitinase Negatively Regulates High Glucose-Induced NF-κB Inflammatory Signaling in Mesangial Cells
por: Li, Yanhui, et al.
Publicado: (2017)

Downregulation of LEF1 Impairs Myeloma Cell Growth Through Modulating CYLD/NF-κB Signaling
por: Zhang, Guihua, et al.
Publicado: (2021)

A Reporter Screen in a Human Haploid Cell Line Identifies CYLD as a Constitutive Inhibitor of NF-κB
por: Lee, Clarissa C., et al.
Publicado: (2013)

CYLD in health and disease
por: Marín-Rubio, José L., et al.
Publicado: (2023)

Downregulation of m(6)A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-κB Pathway
por: Wang, Jin, et al.
Publicado: (2021)

SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling
por: Elliott, Paul R., et al.
Publicado: (2016)

Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma
por: Suenaga, Naoki, et al.
Publicado: (2019)

PKCθ/β and CYLD Are Antagonistic Partners in the NFκB and NFAT Transactivation Pathways in Primary Mouse CD3(+) T Lymphocytes
por: Thuille, Nikolaus, et al.
Publicado: (2013)

Blocking Notch signal in myeloid cells alleviates hepatic ischemia reperfusion injury by repressing the activation of NF-κB through CYLD
por: Yu, Heng-Chao, et al.
Publicado: (2016)

CYLD suppression enhances the pro-inflammatory effects and hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes by enhancing NF-κB activation
por: Zhang, Le-meng, et al.
Publicado: (2018)

MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas
por: Minderman, Marthe, et al.
Publicado: (2023)

SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes
por: Kupka, Sebastian, et al.
Publicado: (2016)

CYLD and SUMO in neuroblastoma therapy
por: Masoumi, Katarzyna Chmielarska, et al.
Publicado: (2016)

CYLD Promotes TNF-α-Induced Cell Necrosis Mediated by RIP-1 in Human Lung Cancer Cells
por: Lin, Xing, et al.
Publicado: (2016)

A novel large deletion of the CYLD gene causes CYLD cutaneous syndrome in a Chinese family
por: Zhu, Ruizheng, et al.
Publicado: (2020)

Rare CYLD Variants in Chinese Patients With Amyotrophic Lateral Sclerosis
por: Gu, Xiaojing, et al.
Publicado: (2021)

CYLD tumour supressor regulates ciligenesis
por: Eguether, T, et al.
Publicado: (2012)

miR-186 suppressed CYLD expression and promoted cell proliferation in human melanoma
por: Qiu, Haijiang, et al.
Publicado: (2016)

CYLD Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Regulating NDRG1
por: Lin, Yanling, et al.
Publicado: (2020)

The Tumor Suppressor CYLD Inhibits Mammary Epithelial to Mesenchymal Transition by the Coordinated Inhibition of YAP/TAZ and TGFβ Signaling
por: Pseftogas, Athanasios, et al.
Publicado: (2020)

The deubiquitinase CYLD is a specific checkpoint of the STING antiviral signaling pathway
por: Zhang, Lele, et al.
Publicado: (2018)

Two COX-2 inhibitors induce apoptosis in human erythroleukemia K562cells by modulating NF-κB and FHC pathways
por: Norouzi, Shaghayegh, et al.
Publicado: (2016)

UVB radiation represses CYLD expression in melanocytes
por: Kuphal, Silke, et al.
Publicado: (2017)

The cylindromatosis (CYLD) gene and head and neck tumorigenesis
por: Verhoeft, Krista Roberta, et al.
Publicado: (2016)

Genetic Testing in CYLD Cutaneous Syndrome: An Update
por: Nagy, Nikoletta, et al.
Publicado: (2021)

Gynaecological cylindroma in association with CYLD gene mutation
por: Khoury, Emma, et al.
Publicado: (2022)

Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation
por: Erol, Adnan
Publicado: (2022)

The Tumour Suppressor CYLD Is Required for Clathrin-Mediated Endocytosis of EGFR and Cetuximab-Induced Apoptosis in Head and Neck Squamous Cell Carcinoma
por: Liu, Rin, et al.
Publicado: (2021)

Syndecan-4 negatively regulates antiviral signalling by mediating RIG-I deubiquitination via CYLD
por: Lin, Wei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_435fh0qfn42i3kip7tcek0voa2